Search Constraints
Search Results
-
ThesisAdamian, YvessMetastatic breast cancers carry a 5-year survival prognosis of less than 20%. Thus, it is highly desirable to identify therapeutic strategies that specifically target both primary and metastatic tumors. It is generally accepted that epithelial-mesench . . .
-
ArticleKatz, MatthewNext-generation sequencing (NGS) can identify and validate new biomarkers of cancer onset, progression and therapy resistance. Substantial archives of formalin-fixed, paraffin-embedded (FFPE) cancer samples from patients represent a rich resource for . . .
-
ArticleGharibi, ArmenPancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy that affects nearly 5, patients each year. The overall 5-year survival rate for this malignancy remains the lowest of any cancer at around 7% due to limited diagnostic methods, disease agg . . . -
ArticleWolfenden, LaurelinPancreatic ductal adenocarcinoma (PDAC) has single-digit 5-year survival rates at <7%. There is a dire need to improve pre-malignant detection methods and identify new therapeutic targets for abrogating PDAC progression. To this end, we mined our prev . . .
-
ArticleGharibi, ArmenPancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy that affects nearly 5, patients each year. The overall 5-year survival rate for this malignancy remains the lowest of any cancer at around 7% due to limited diagnostic methods, disease agg . . .